An Inhalable drug delivery device is a medical device used for delivering medication into the body via the lungs. It is mainly used in the treatment of asthma and chronic obstructive pulmonary disease. Zanamivir, used to treat influenza, must be administered via inhaler. To reduce deposition in the mouth and throat, and to reduce the need for precise synchronization of the start of inhalation with actuation of the device, Inhalable drug delivery devices are sometimes used with a complementary spacer or holding chamber device.
MARKET SCOPE
The "Global Inhalable Drug Delivery Devices Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the inhalable drug delivery devices market with detailed market segmentation product, end user, and geography. The report provides key statistics on the market status of the leading inhalable drug delivery devices market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
? On the basis of product, the market is segmented into pressurized metered-dose inhalers, nebulizers, dry powder inhalers, thermal vaporization aerosol devices, others.
? On the basis of end user, the market is segmented into hospitals and clinics, ambulatory care center, home care, others.
MARKET DYNAMICS
Drivers
? Increasing prevalence and incidence asthmatic cases
? Chronic and acute diseases in the global population can leads to major inhalation problem
Restraints
? Regulatory Issues
? Pricing Pressure
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The inhalable drug delivery devices market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the inhalable drug delivery devices market in these regions.
IMPACT OF COVID-19 ON INHALABLE DRUG DELIVERY DEVICES MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The global outbreak of COVID-19 has impacted all the industries.
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others).
MARKET PLAYERS
The report covers key developments in the inhalable drug delivery devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from inhalable drug delivery devices market are anticipated to lucrative growth opportunities in the future with the rising demand for inhalable drug delivery devices in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the inhalable drug delivery devices market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
? Bespak
? Propeller Health
? Boehringer Ingelheim International GmbH
? OMRON Corporation
? GlaxoSmithKline plc
? AstraZeneca
? Sunovion Pharmaceuticals Inc.
? Pfizer Inc.
? F. Hoffmann-La Roche Ltd
? Monaghan Medical Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.